CN101760447B - Method for inducing and acclimating epidermal stem cells into nerve cells - Google Patents
Method for inducing and acclimating epidermal stem cells into nerve cells Download PDFInfo
- Publication number
- CN101760447B CN101760447B CN 200910210397 CN200910210397A CN101760447B CN 101760447 B CN101760447 B CN 101760447B CN 200910210397 CN200910210397 CN 200910210397 CN 200910210397 A CN200910210397 A CN 200910210397A CN 101760447 B CN101760447 B CN 101760447B
- Authority
- CN
- China
- Prior art keywords
- medium
- stem cells
- cells
- epidermal stem
- epidermal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000002514 epidermal stem cell Anatomy 0.000 title claims abstract description 72
- 238000000034 method Methods 0.000 title claims abstract description 27
- 210000002569 neuron Anatomy 0.000 title claims abstract description 19
- 230000001939 inductive effect Effects 0.000 title claims abstract description 12
- 210000004027 cell Anatomy 0.000 claims abstract description 62
- 230000006698 induction Effects 0.000 claims abstract description 56
- 210000002615 epidermis Anatomy 0.000 claims abstract description 10
- 239000002609 medium Substances 0.000 claims description 51
- 210000001519 tissue Anatomy 0.000 claims description 18
- 241000282414 Homo sapiens Species 0.000 claims description 14
- 238000012423 maintenance Methods 0.000 claims description 14
- 230000001537 neural effect Effects 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 12
- 210000005036 nerve Anatomy 0.000 claims description 12
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims description 9
- 229930002330 retinoic acid Natural products 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 229960001727 tretinoin Drugs 0.000 claims description 9
- NIJJYAXOARWZEE-UHFFFAOYSA-N Valproic acid Chemical compound CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 claims description 8
- 239000006143 cell culture medium Substances 0.000 claims description 8
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims description 8
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 6
- 230000000996 additive effect Effects 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 6
- 230000029087 digestion Effects 0.000 claims description 6
- 238000012546 transfer Methods 0.000 claims description 6
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 4
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 4
- 102000004058 Leukemia inhibitory factor Human genes 0.000 claims description 4
- 108090000581 Leukemia inhibitory factor Proteins 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 239000001963 growth medium Substances 0.000 claims description 4
- 230000001965 increasing effect Effects 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 229940054269 sodium pyruvate Drugs 0.000 claims description 4
- 229960000604 valproic acid Drugs 0.000 claims description 4
- 108090000145 Bacillolysin Proteins 0.000 claims description 3
- 239000004255 Butylated hydroxyanisole Substances 0.000 claims description 3
- 102000035092 Neutral proteases Human genes 0.000 claims description 3
- 108091005507 Neutral proteases Proteins 0.000 claims description 3
- 229940043253 butylated hydroxyanisole Drugs 0.000 claims description 3
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims description 3
- 235000019282 butylated hydroxyanisole Nutrition 0.000 claims description 3
- 239000006285 cell suspension Substances 0.000 claims description 3
- 239000012228 culture supernatant Substances 0.000 claims description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 2
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims 2
- 230000004069 differentiation Effects 0.000 abstract description 18
- 210000002444 unipotent stem cell Anatomy 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000009466 transformation Effects 0.000 abstract description 2
- 210000002510 keratinocyte Anatomy 0.000 description 15
- 210000000130 stem cell Anatomy 0.000 description 15
- 239000007788 liquid Substances 0.000 description 14
- 238000001962 electrophoresis Methods 0.000 description 12
- 239000000499 gel Substances 0.000 description 12
- 238000010166 immunofluorescence Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 9
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 8
- 102100025304 Integrin beta-1 Human genes 0.000 description 8
- 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 7
- 102100038081 Signal transducer CD24 Human genes 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000000684 flow cytometry Methods 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000010839 reverse transcription Methods 0.000 description 6
- 238000003757 reverse transcription PCR Methods 0.000 description 6
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 5
- 102000008730 Nestin Human genes 0.000 description 5
- 108010088225 Nestin Proteins 0.000 description 5
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 210000003953 foreskin Anatomy 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 210000005055 nestin Anatomy 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229920000936 Agarose Polymers 0.000 description 4
- 101000835745 Homo sapiens Teratocarcinoma-derived growth factor 1 Proteins 0.000 description 4
- 102100033237 Pro-epidermal growth factor Human genes 0.000 description 4
- 102100026404 Teratocarcinoma-derived growth factor 1 Human genes 0.000 description 4
- 210000004504 adult stem cell Anatomy 0.000 description 4
- 229960000074 biopharmaceutical Drugs 0.000 description 4
- 210000001185 bone marrow Anatomy 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 210000001339 epidermal cell Anatomy 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
- 102100039289 Glial fibrillary acidic protein Human genes 0.000 description 3
- 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 3
- 101000975474 Homo sapiens Keratin, type I cytoskeletal 10 Proteins 0.000 description 3
- 101000614436 Homo sapiens Keratin, type I cytoskeletal 14 Proteins 0.000 description 3
- 101000998011 Homo sapiens Keratin, type I cytoskeletal 19 Proteins 0.000 description 3
- 101001046960 Homo sapiens Keratin, type II cytoskeletal 1 Proteins 0.000 description 3
- 101001056473 Homo sapiens Keratin, type II cytoskeletal 5 Proteins 0.000 description 3
- 101000976622 Homo sapiens Zinc finger protein 42 homolog Proteins 0.000 description 3
- 102100023970 Keratin, type I cytoskeletal 10 Human genes 0.000 description 3
- 102100040445 Keratin, type I cytoskeletal 14 Human genes 0.000 description 3
- 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 description 3
- 102100022905 Keratin, type II cytoskeletal 1 Human genes 0.000 description 3
- 102100025756 Keratin, type II cytoskeletal 5 Human genes 0.000 description 3
- 108700021430 Kruppel-Like Factor 4 Proteins 0.000 description 3
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 3
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 3
- 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 3
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 3
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 3
- 102100023550 Zinc finger protein 42 homolog Human genes 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 239000013592 cell lysate Substances 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000001671 embryonic stem cell Anatomy 0.000 description 3
- 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 210000003061 neural cell Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 102000004266 Collagen Type IV Human genes 0.000 description 2
- 108010042086 Collagen Type IV Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 description 2
- 108010022222 Integrin beta1 Proteins 0.000 description 2
- 102000012355 Integrin beta1 Human genes 0.000 description 2
- -1 Nanog Proteins 0.000 description 2
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 2
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 2
- 238000010240 RT-PCR analysis Methods 0.000 description 2
- 102100024270 Transcription factor SOX-2 Human genes 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 210000004498 neuroglial cell Anatomy 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000012192 staining solution Substances 0.000 description 2
- 210000003014 totipotent stem cell Anatomy 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- WAPPRYMYMNVAFR-UHFFFAOYSA-N 2-sulfanylethanol Chemical compound OCCS.OCCS WAPPRYMYMNVAFR-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 101100298998 Caenorhabditis elegans pbs-3 gene Proteins 0.000 description 1
- 238000000116 DAPI staining Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000614439 Homo sapiens Keratin, type I cytoskeletal 15 Proteins 0.000 description 1
- 101001094700 Homo sapiens POU domain, class 5, transcription factor 1 Proteins 0.000 description 1
- 102100040443 Keratin, type I cytoskeletal 15 Human genes 0.000 description 1
- 108010050345 Microphthalmia-Associated Transcription Factor Proteins 0.000 description 1
- 102100030157 Microphthalmia-associated transcription factor Human genes 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000002293 adipogenic effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 230000009668 clonal growth Effects 0.000 description 1
- 210000001728 clone cell Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
- 102000007236 involucrin Human genes 0.000 description 1
- 108010033564 involucrin Proteins 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 239000013630 prepared media Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种表皮干细胞诱导驯化为神经细胞的方法,该方法是通过将eplife培养基与诱导培养基进行不同比例的混合,使表皮干细胞有充足的时间适应eplife培养基不断减少诱导培养基逐渐增加,并有利于减少向表皮分化,增加向目的细胞转变的机率。本发明方法既简单又非常有效的将表皮干细胞定向诱导驯化为神经细胞。并克服了本领域技术人员的偏见,首次颠覆表皮干细胞是单能干细胞的论断,证明其具有多向分化潜能。
The invention discloses a method for inducing and domesticating epidermal stem cells into nerve cells. The method is to mix the eplife medium and the induction medium in different proportions, so that the epidermal stem cells have sufficient time to adapt to the eplife medium and continuously reduce the induction medium Gradually increase, and it is beneficial to reduce the differentiation to the epidermis and increase the probability of transformation to the target cell. The method of the present invention is simple and very effective for directional induction and domestication of epidermal stem cells into nerve cells. And overcome the prejudice of those skilled in the art, for the first time subvert the conclusion that epidermal stem cells are unipotent stem cells, and prove that they have multi-directional differentiation potential.
Description
技术领域 technical field
本发明涉及一种诱导细胞的方法,具体地说是利用表皮干细胞定向诱导驯化为神经细胞的方法。The invention relates to a method for inducing cells, in particular to a method for directional induction and domestication of epidermal stem cells into nerve cells.
背景技术 Background technique
人类对表皮干细胞的研究,已有几十年历史,但由于其难以诱导分化一直被认为是单能干细胞,即仅能分化成为表皮的相关成分。再生医学在医学领域中炙手可热,干细胞的研究在再生医学领域中已占据了重要的低位,干细胞由于其具有多分化潜能,在特定的条件下可以分化为各种组织器官的能力得到科学家们的关注。胚胎干细胞是一种全能干细胞,其能分化为除胎盘外的所有组织和器官。但由于胚胎干细胞的研究涉及伦理学的诸多问题,所以本领域技术人员一直致力于寻找另外一种全能干细胞来替代胚胎干细胞。Humans have been studying epidermal stem cells for decades, but due to their difficulty in inducing differentiation, they have always been considered as unipotent stem cells, that is, they can only differentiate into related components of the epidermis. Regenerative medicine is hot in the field of medicine, and the research on stem cells has occupied an important position in the field of regenerative medicine. Stem cells, due to their multi-differentiation potential, can differentiate into various tissues and organs under specific conditions have attracted the attention of scientists. . Embryonic stem cells are totipotent stem cells that can differentiate into all tissues and organs except the placenta. However, because research on embryonic stem cells involves many ethical issues, those skilled in the art have been working on finding another kind of totipotent stem cells to replace embryonic stem cells.
人们把目标逐渐锁定在成体干细胞上。目前,本领域技术人员已经成功的将MSC(间充质干细胞),ADSC(脂肪干细胞)等成体干细胞诱导分化为其他类型的细胞,如软骨细胞、骨细胞、心肌细胞等。MSC最初在骨髓中发现,因其具有多向分化潜能、造血支持和促进干细胞植入、免疫调控和自我复制等特点而日益受到人们的关注。如间充质干细胞在体内或体外特定的诱导条件下,可分化为脂肪、骨、软骨、肌肉、肌腱、韧带、神经、肝、心肌、内皮等多种组织细胞,连续传代培养和冷冻保存后仍具有多向分化潜能,可作为理想的种子细胞用于衰老和病变引起的组织器官损伤修复,因此,目前将MSC作为一种骨组织工程的种子细胞与支架材料可修复损伤的组织在临床已普遍应用。间充质干细胞(MSCs)是属于中胚层的一类多能干细胞,主要存在于结缔组织和器官间质中,以骨髓组织中含量最为丰富,由于骨髓是其主要来源,因此统称为骨髓间充质干细胞。但是利用MSC诱导分化神经细胞的弊端为:MSC的来源有限,取材又很麻烦,从取材上比较受局限;MSC诱导培养周期长,培养过程复杂,不易培养和扩增,因此MSC的应用遇到很多阻碍。People are gradually targeting adult stem cells. At present, those skilled in the art have successfully induced MSC (mesenchymal stem cells), ADSC (adipogenic stem cells) and other adult stem cells to differentiate into other types of cells, such as chondrocytes, bone cells, cardiomyocytes, etc. Originally found in bone marrow, MSCs have attracted increasing attention because of their multi-lineage differentiation potential, hematopoietic support and promotion of stem cell implantation, immune regulation and self-replication. For example, mesenchymal stem cells can be differentiated into fat, bone, cartilage, muscle, tendon, ligament, nerve, liver, cardiac muscle, endothelial and other tissue cells under specific induction conditions in vivo or in vitro, after continuous subculture and cryopreservation It still has multi-directional differentiation potential and can be used as an ideal seed cell for the repair of tissue and organ damage caused by aging and disease. Therefore, MSC is currently used as a seed cell and scaffold material for bone tissue engineering to repair damaged tissues in clinical practice. Universal application. Mesenchymal stem cells (MSCs) are a type of pluripotent stem cells belonging to the mesoderm. They mainly exist in connective tissue and organ interstitium, and are most abundant in bone marrow tissue. Since bone marrow is its main source, they are collectively called bone marrow mesenchymal cells. stem cells. However, the disadvantages of using MSCs to induce differentiation of nerve cells are: the source of MSCs is limited, and the materials are very troublesome, and the materials are relatively limited; Lots of obstacles.
表皮干细胞又称专一性干细胞或单能细胞,是指只能产生一种细胞类型,但具有自更新属性的细胞。本领域技术人员一直将表皮干细胞归为单能细胞。对于表皮干细胞的应用范围也受单能细胞的影响而受限。Epidermal stem cells, also known as specific stem cells or unipotent cells, refer to cells that can only produce one type of cell, but have self-renewal properties. Those skilled in the art have always classified epidermal stem cells as unipotent cells. The scope of application of epidermal stem cells is also limited by the influence of unipotent cells.
发明内容 Contents of the invention
本发明的目的在于弥补现有技术的不足,提供一种将具有多潜能的成体干细胞通过驯化诱导定向分化为神经细胞的方法。为以后临床组织工程的应用提供一种潜在的种子细胞,可以广泛应用在创伤修复、基因治疗、美容等方面,为人类提供方便。The purpose of the present invention is to make up for the deficiencies of the prior art, and to provide a method for directional differentiation of pluripotent adult stem cells into nerve cells through domestication induction. It provides a potential seed cell for the application of clinical tissue engineering in the future, which can be widely used in wound repair, gene therapy, beauty treatment, etc., and provides convenience for human beings.
为了达到上述目的,本发明的思路为:在对表皮干细胞的深入研究中,我们了解到表皮的附件毛囊、汗腺都存在多向分化潜能的干细胞,并且与表皮毗邻的真皮也存在这样的干细胞,难道作为机体含量最丰富的干细胞,就是仅仅只能分化表皮细胞的单能干细胞吗?带着这个疑问,我们开始对表皮干细胞多能性进行了漫长的研究。In order to achieve the above object, the idea of the present invention is: in the in-depth study of epidermal stem cells, we have learned that there are stem cells with multi-directional differentiation potential in the appendage hair follicles and sweat glands of the epidermis, and there are also such stem cells in the dermis adjacent to the epidermis. Could it be that the most abundant stem cells in the body are unipotent stem cells that can only differentiate epidermal cells? With this question in mind, we began a lengthy study on the pluripotency of epidermal stem cells.
在研究过程中,我们充分认识了表皮干细胞的相关特性,也了解到表皮干细胞在eplife培养系统问世之前是一种非常难以培养的干细胞,它必须培养在低钙离子浓度或无钙离子的培养系统中才能维持其干性减少向表皮分化。Eplife培养系统不仅为其提供了这样的环境还加入了许多生长因子更加有利于表皮干细胞的干性的维持,且在我们的实验过程中也发现在原代培养后可以使表皮干细胞的干性上升。但这种生长特点又给诱导分化带来了难题,诱导分化的目的细胞需要一定浓度的钙离子存在,这是其发育所必须的。In the process of research, we have fully understood the relevant characteristics of epidermal stem cells, and also learned that epidermal stem cells were a kind of stem cells that were very difficult to cultivate before the advent of the eplife culture system. It must be cultured in a culture system with low calcium ion concentration or no calcium ion In order to maintain its dryness and reduce differentiation to the epidermis. The Eplife culture system not only provides such an environment, but also adds many growth factors that are more conducive to the maintenance of the stemness of epidermal stem cells, and during our experiments, we also found that the stemness of epidermal stem cells can increase after primary culture. However, this growth characteristic has brought difficulties to the induction of differentiation. The target cells for induction of differentiation require the presence of a certain concentration of calcium ions, which is necessary for their development.
因此怎样保持表皮干细胞的干性相对稳定和积极引导其向目的细胞分化成为本发明需解决的首要问题。由于eplife培养系统对表皮干细胞干性的维持具有明确的意义(已被实验证实),因此我们选择了像调制鸡尾酒一样的方法将eplife培养基与诱导培养基进行不同比例的混合,使表皮干细胞有充足的时间适应eplife培养基不断减少诱导培养基逐渐增加,并有利于减少向表皮分化增加向目的细胞转变的机率。我们将这种培养过程称之为驯化。Therefore, how to keep the stemness of epidermal stem cells relatively stable and actively guide them to differentiate into target cells has become the primary problem to be solved in the present invention. Since the eplife culture system has a definite significance for the maintenance of the stemness of epidermal stem cells (it has been confirmed by experiments), we chose to mix the eplife medium and the induction medium in different proportions in the same way as making a cocktail, so that the epidermal stem cells have Sufficient time to adapt to the continuous reduction of the eplife medium and the gradual increase of the induction medium is beneficial to reduce the probability of the transformation from epidermal differentiation to target cells. We call this training process domestication.
本发明所采用的具体的技术方案为:The concrete technical scheme that the present invention adopts is:
一种表皮干细胞诱导驯化为神经细胞的方法,其特征在于,该方法的具体步骤是A method for inducing and acclimating epidermal stem cells into nerve cells, characterized in that the specific steps of the method are:
(1)将表皮干细胞经培养后,取密度大于80%~95%的表皮干细胞,PBS洗细胞两遍,更换新鲜Eplife培养基,20~30h后在1%~5%神经诱导培养基一和95%~99%干性维持培养基的混合培养基中培养30~40h;(1) After the epidermal stem cells are cultured, take the epidermal stem cells with a density greater than 80%-95%, wash the cells twice with PBS, replace with fresh Eplife medium, and after 20-30h, in 1%-5% neural induction medium and Cultivate in the mixed medium of 95%-99% dry maintenance medium for 30-40 hours;
(2)将培养基更换15%~25%神经诱导培养基二和75%~85%干性维持培养基继续培养3~5天;(2) Replace the culture medium with 15%-25%
(3)以后每3~5天更换一次培养基;每次更换神经诱导培养基二成分增加15%~25%,直到神经诱导培养基二成分为100%而无干性维持培养基为止。(3) The medium is replaced every 3-5 days thereafter; the second component of the neural induction medium is increased by 15% to 25% each time, until the second component of the neural induction medium is 100% without dry maintenance medium.
上述的表皮干细胞诱导驯化为神经细胞的方法,所述的神经诱导培养基一成分及用量为:In the above-mentioned method for inducing and domesticating epidermal stem cells into nerve cells, the composition and dosage of the nerve induction medium are as follows:
DMEM/F122%FBS;40~45ng/ml基本成纤维细胞生长因子b-FGF;15~25ng/ml表皮生长因子EGF;0.3~0.5mM视黄酸(retinoic acid);0.3~0.5mM丙戊酸(valproic acid);1500~2000U/ml白血病抑制因子(leukemiainhibitory factor);80~100mM丙酮酸钠(sodium pyruvate);0.5mM β-巯基乙醇(β-mercaptoethanol);DMEM/F122% FBS; 40-45ng/ml basic fibroblast growth factor b-FGF; 15-25ng/ml epidermal growth factor EGF; 0.3-0.5mM retinoic acid (retinoic acid); 0.3-0.5mM valproic acid (valproic acid); 1500~2000U/ml leukemia inhibitory factor (leukemia inhibitory factor); 80~100mM sodium pyruvate (sodium pyruvate); 0.5mM β-mercaptoethanol (β-mercaptoethanol);
上述的表皮干细胞诱导驯化为神经细胞的方法,所述的神经诱导培养基二成分及用量为:In the above-mentioned method for inducing and domesticating epidermal stem cells into nerve cells, the two components and dosages of the nerve induction medium are:
DMEM/F12 2%FBS;15~20ng/ml基本成纤维细胞生长因子b-FGF;15~20ng/ml表皮生长因子EGF;0.5uM视黄酸(retinoic acid);1×B27;100ug/ml丁羟基茴香醚(butylated hydroxyanisole)。DMEM/
上述的表皮干细胞诱导驯化为神经细胞的方法,所述干性维持培养基的成分及用量为:The above-mentioned method for inducing and acclimating epidermal stem cells into nerve cells, the composition and dosage of the stem maintenance medium are:
94~98%Epilife、1%PS双抗和1~5%HKGS添加剂。94-98% Epilife, 1% PS double antibody and 1-5% HKGS additive.
上述的表皮干细胞诱导驯化为神经细胞的方法,所述步骤(1)中所使用的表皮干细胞的制备步骤如下:The above-mentioned method for inducing and acclimating epidermal stem cells into nerve cells, the preparation steps of the epidermal stem cells used in the step (1) are as follows:
(1)取离体时间1~4h,4℃保存的人表皮组织浸泡于稀碘伏溶液中1min,PBS/生理盐水冲洗3次,去除脂肪组织,修剪成1cm2组织块;(1) Take the human epidermal tissue that has been isolated for 1 to 4 hours and stored at 4°C, soak it in dilute povidone iodine solution for 1 minute, wash it with PBS/normal saline for 3 times, remove the fat tissue, and trim it into 1cm2 tissue pieces;
(2)将组织块置于含中性蛋白酶溶液中4℃处理14~16h或直接置于37℃孵箱处理3h以上;(2) Place the tissue block in a neutral protease-containing solution for 14-16 hours at 4°C or directly in a 37°C incubator for more than 3 hours;
(3)4℃的PBS冲洗标本3次;分离表皮;(3) Rinse the
(4)剪碎后加入等体积0.25%Typsin-EDTA 3~8ml,于37℃处理30~90min,用3~8ml MEFs培养基终止消化,再通过剧烈振荡分层;(4) After chopping, add an equal volume of 0.25% Typsin-EDTA 3-8ml, treat at 37°C for 30-90min, stop digestion with 3-8ml MEFs medium, and then layer by vigorous shaking;
(5)吸取中层的细胞悬液转移到另一支离心管中,离心600~1000rpm3~8min;(5) Transfer the cell suspension in the middle layer to another centrifuge tube, and centrifuge at 600-1000rpm for 3-8min;
(6)弃上清,用人表皮干细胞培养基重悬;(6) Discard the supernatant and resuspend with human epidermal stem cell culture medium;
(7)移至培养瓶中,静置30~90min后,弃培养上清并用PBS冲洗2~3次,更换新鲜表皮干细胞培养基;置于37℃、5%CO2孵箱继续培养。(7) Transfer to a culture bottle, let stand for 30-90 minutes, discard the culture supernatant and rinse with PBS 2-3 times, replace with fresh epidermal stem cell medium; place in a 37°C, 5% CO 2 incubator to continue culturing.
上述的表皮干细胞诱导驯化为神经细胞的方法,所述人表皮干细胞培养基组成94~98%Epilife、1%PS双抗、1%HKGS添加剂。本发明的优点及效益是:本发明发明人经过多次试验证实,本发明方法既简单又非常有效的将表皮干细胞定向诱导驯化为神经细胞,并克服了本领域技术人员的偏见,首次颠覆表皮干细胞是单能干细胞的论断,证明其具有多向分化潜能。In the above method for inducing and domesticating epidermal stem cells into neurons, the culture medium for human epidermal stem cells consists of 94-98% Epilife, 1% PS double antibody, and 1% HKGS additive. The advantages and benefits of the present invention are: the inventors of the present invention have confirmed through many experiments that the method of the present invention is simple and very effective in directional induction and domestication of epidermal stem cells into nerve cells, and overcomes the prejudice of those skilled in the art, subverting the epidermis for the first time. The assertion that stem cells are unipotent stem cells demonstrates their multilineage differentiation potential.
附图说明 Description of drawings
图1为免疫荧光检测表皮干细胞特征标记CD90,CD24,CD29,其中CD29阳性率大于15%,CD24阳性率大于80%,CD29阳性率大于90%;Figure 1 is the characteristic markers of CD90, CD24 and CD29 detected by immunofluorescence, wherein the positive rate of CD29 is greater than 15%, the positive rate of CD24 is greater than 80%, and the positive rate of CD29 is greater than 90%;
图2为流式细胞仪检测人包皮基底层来源的未分化角质化细胞。CD90,CD24,β1 integrin为分化角质化细胞的表面标记。其中每组图左图为对照组,右图为检测的表皮干细胞组。结果显示获得的角质化细胞干性强;Figure 2 is flow cytometry detection of undifferentiated keratinocytes derived from the basal layer of human foreskin. CD90, CD24, and β1 integrin are surface markers of differentiated keratinocytes. The left picture of each group is the control group, and the right picture is the detected epidermal stem cell group. The results showed that the stemness of the obtained keratinocytes was strong;
图3为RT-PCR鉴定培养的各时间点的表皮干细胞中干性基因OCT4,SOX2,Klf4,Nanog,c-myc,CRIPTO,REX1,KRT14,分化标记KRT1,KRT5,KRT10,KRT19,其他细胞标记MTTF,TYR,c-kit的表达情况;Figure 3 is RT-PCR identification of stemness genes OCT4, SOX2, Klf4, Nanog, c-myc, CRIPTO, REX1, KRT14, differentiation markers KRT1, KRT5, KRT10, KRT19, and other cell markers in epidermal stem cells at each time point of culture Expression of MTTF, TYR, c-kit;
图4为表皮细胞的起始状态及诱导两天后的变化;Figure 4 is the initial state of epidermal cells and the changes after two days of induction;
图5为驯化诱导角质化细胞产生神经细胞系,A代表诱导前的角质化细胞和诱导两天后的细胞;B箭头指示为诱导两周后角质化来源的Nestin阳性的细胞;C箭头指示诱导三周后神经特异标记β3-tublin免疫荧光结果;D箭头指示为GFAP阳性的细胞,右图为角质化细胞诱导来的GFAP阳性的典型的胶质细胞分化形态;E的为神经诱导三周后RT-PCR分析基因的表达,M,marker;K,分化的角质化细胞;S,sample;Figure 5 shows the generation of neural cell lines from domesticated induced keratinocytes. A represents keratinocytes before induction and cells two days after induction; B arrows indicate Nestin-positive cells derived from keratinization two weeks after induction; C arrows indicate induction three Immunofluorescence results of nerve-specific marker β3-tublin after one week; D arrows indicate GFAP-positive cells, and the right picture shows keratinocyte-induced GFAP-positive typical glial cell differentiation morphology; E is RT three weeks after nerve induction -PCR analysis of gene expression, M, marker; K, differentiated keratinocytes; S, sample;
图6定向诱导后神经(nestin)特异性染色阳性。Figure 6 Nerve (nestin)-specific staining was positive after directional induction.
具体实施方式 Detailed ways
实施例1诱导驯化前表皮干细胞的制备Example 1 Preparation of Epidermal Stem Cells Before Induction and Domestication
一、表皮干细胞的制备:1. Preparation of epidermal stem cells:
直接来源和原始来源:经患者同意取自301医院外科门诊健康包皮环切术患者。Direct source and original source: With the consent of the patient, it was collected from healthy circumcision patients in the Surgical Outpatient Department of 301 Hospital.
(1)取新鲜的成人包皮(离体时间约1~4h,4℃保存);(1) Take fresh adult foreskin (in vitro time is about 1-4 hours, stored at 4°C);
(2)将包皮浸泡于稀碘伏溶液(含碘伏20%)中1min;(2) soak the foreskin in dilute iodophor solution (containing
(3)PBS/生理盐水冲洗3次洗去血块(防止影响酶的消化);(3) Rinse with PBS/normal saline for 3 times to remove blood clots (to prevent affecting the digestion of enzymes);
(4)修剪包皮,去除脂肪组织,再用PBS/生理盐水冲洗数次,最后剪成1cm2左右的组织方块;(4) Trim the foreskin, remove adipose tissue, rinse several times with PBS/normal saline, and finally cut into tissue squares of about 1cm2 ;
(5)将组织块置于含中性蛋白酶(3mg/ml;D-hanks做溶剂)溶液的6cm皿中4℃处理14-16h,如果处理不够还可置于37℃孵箱(也可直接置于37℃孵箱处理3h以上——随时观察处理效果);(5) Place the tissue block in a 6cm dish containing neutral protease (3mg/ml; D-hanks as solvent) solution and treat it at 4°C for 14-16h. If the treatment is not enough, it can also be placed in a 37°C incubator (or directly Place in a 37°C incubator for more than 3 hours—observe the treatment effect at any time);
(6)4℃的PBS冲洗标本3次;(6) Rinse the
(7)分离表皮(用消毒镊撕取);(7) Separate the epidermis (tear it with sterile tweezers);
在小瓶中剪碎后加入等体积0.25%Typsin-EDTA中(胰酶的浓度为0.25%,EDTA的浓度为0.05%,将上述浓度的胰酶和EDTA按1∶1混合)共4ml,于37℃处理30~90min(样本年龄越小消化时间也越长,一般<30岁37℃消化60min至90min,一般>30岁37℃消化45min),用4ml含血清的培养基(MEFs培养基)终止消化,再通过剧烈振荡分层:角质层(上层)、细胞层(中层)、组织(下层);Cut it into pieces in the vial and add an equal volume of 0.25% Typsin-EDTA (the concentration of trypsin is 0.25%, the concentration of EDTA is 0.05%, the above-mentioned concentration of trypsin and EDTA are mixed by 1:1) a total of 4ml, at 37 Treat at ℃ for 30-90 minutes (the younger the sample age, the longer the digestion time, generally <30 years old, digest at 37°C for 60 minutes to 90 minutes, generally >30 years old, digest at 37°C for 45 minutes), stop with 4ml of serum-containing medium (MEFs medium) Digestion, and then stratified by vigorous shaking: stratum corneum (upper layer), cell layer (middle layer), tissue (lower layer);
(8)小心吸取中层的细胞悬液转移到另一支离心管中,离心1000rpm 5min;(8) Carefully transfer the cell suspension in the middle layer to another centrifuge tube, and centrifuge at 1000rpm for 5min;
(9)弃上清,用人表皮干细胞培养基重悬;(9) Discard the supernatant and resuspend with human epidermal stem cell culture medium;
(10)移至培养瓶(用100μg/ml IV型胶原预处理过)中,静置60min(干细胞惰性,先贴壁)后,弃培养上清并用PBS冲洗2次,更换新鲜表皮干细胞培养基;置于37℃、5%CO2孵箱继续培养。(10) Transfer to a culture bottle (pretreated with 100 μg/ml type IV collagen), let it stand for 60 minutes (stem cells are inert, adhere to the wall first), discard the culture supernatant and wash it twice with PBS, and replace with fresh epidermal stem cell culture medium ; Place in a 37°C, 5% CO 2 incubator to continue culturing.
注:人表皮干细胞培养基组成Note: Human epidermal stem cell culture medium composition
98%Epilife(Cascade Biologics,cat.no.M-EPI-500-CA)98% Epilife (Cascade Biologics, cat. no. M-EPI-500-CA)
1%PS(双抗Invitrogen,cat.no.15070)1% PS (double antibody Invitrogen, cat.no.15070)
1%、添加剂(HKGS,Cascade Biologics,cat.no.S-001-5)1%, additive (HKGS, Cascade Biologics, cat.no.S-001-5)
二、表皮干细胞诱导驯化前的生长状态:2. Growth state of epidermal stem cells before induction and domestication:
1、新鲜的表皮干培养1天后,更换培养基(目的是除去死细胞)。1. After 1 day of dry culture of fresh epidermis, replace the medium (the purpose is to remove dead cells).
2、一般培养3天后,再此更换人表皮干细胞培养基。这时细胞大多贴壁生长,呈卵石路样,细胞为梭形和卵圆形(细胞壁界限清),并见数量较多的小圆亮细胞,生长在贴壁细胞的上层且呈克隆性生长。2. After 3 days of culture, replace the human epidermal stem cell culture medium again. At this time, most of the cells are attached to the wall and grow in the shape of a cobblestone road. The cells are spindle-shaped and oval (the cell wall boundary is clear), and a large number of small round bright cells are seen, which grow on the upper layer of the adherent cells and show clonal growth. .
三、表皮干细胞的鉴定:3. Identification of epidermal stem cells:
以上方法获取的表皮干细胞是否是我们所需要的表皮干细胞,结合干细胞特征性的分子标记,以及表皮干细胞的特征我们采用RT-PCR(图3)、免疫荧光(图1)、流式细胞术(图3)检测表皮干细胞的标记。Whether the epidermal stem cells obtained by the above method are the epidermal stem cells we need, combined with the characteristic molecular markers of stem cells, and the characteristics of epidermal stem cells, we use RT-PCR (Figure 3), immunofluorescence (Figure 1), flow cytometry ( Figure 3) Detection of markers of epidermal stem cells.
1、鉴定方法:1. Identification method:
为确定上面贴壁的细胞为我们所要的表皮干细胞,我们采用RT-PCR,及其免疫荧光的方法检测其干性分子及特定的分子标记。In order to confirm that the above-adhered cells are the epidermal stem cells we want, we use RT-PCR and its immunofluorescence method to detect its stemness molecules and specific molecular markers.
1.1RT-PCR1.1 RT-PCR
1.1.1RNA的提取1.1.1 Extraction of RNA
(1)将准备好的IPS细胞、表皮干细胞、MEF细胞中的培养基吸弃,用PBS洗细胞两遍。(1) Discard the prepared medium in IPS cells, epidermal stem cells, and MEF cells, and wash the cells twice with PBS.
(2)每个六孔板加入4℃预冷的Tribule裂解液1ml,看到细胞均被裂解开,大约5min。(2) Add 1ml of 4°C pre-cooled Tribule Lysis Solution to each six-well plate, and see that the cells are all lysed, about 5min.
(3)用无核酶枪尖将细胞裂解液吸到1.5ml离心管中。(3) Use a nuclease-free gun tip to pipette the cell lysate into a 1.5ml centrifuge tube.
(4)加入200ul氯仿,上下剧烈震荡四到五次,使其充分混匀。(4) Add 200ul of chloroform, shake vigorously up and down four to five times to make it fully mixed.
(5)12000rpm,5min 4℃.液体分三层,吸取上层透明液体层到新的1.5ml离心管中。(5) 12000rpm, 5min 4°C. The liquid is divided into three layers, and the upper transparent liquid layer is sucked into a new 1.5ml centrifuge tube.
(6)加入等体积的异丙醇,上下颠倒混匀四五次,室温静止10min。(6) Add an equal volume of isopropanol, mix upside down four or five times, and let stand at room temperature for 10 minutes.
(7)12000rpm,5min,4℃此时可见RNA沉淀,弃上清,注意小心操作勿将沉淀块吸出。(7) 12000rpm, 5min, 4°C, RNA precipitation can be seen at this time, discard the supernatant, and be careful not to suck out the precipitate.
(8)加预冷的70%乙醇700ul,12000,2min,4℃,弃上清,重复操作一次。(8) Add 700ul of pre-cooled 70% ethanol, 12000, 2min, 4°C, discard the supernatant, and repeat the operation once.
(9)将RNA中残留的液体晾干,视沉淀体积量加入无核酶水溶解RNA(注意RNA太干不易溶解)(9) Dry the remaining liquid in the RNA, and add nuclease-free water to dissolve the RNA depending on the volume of the precipitate (note that the RNA is too dry and difficult to dissolve)
1.1.2逆转录RNA为CDNA1.1.2 Reverse transcription of RNA to cDNA
(10)按反转录试剂盒配置反转录体系,见表1(10) Configure the reverse transcription system according to the reverse transcription kit, see Table 1
表1Table 1
*RNA加入的多少应视沉淀量而定,最后无核酶水的量应补足到10ul*The amount of RNA added should depend on the amount of precipitation, and the amount of nuclease-free water should be supplemented to 10ul
按上表加入好后,37℃,15min,85℃,5s。-20保存待用。After adding according to the above table, 37°C, 15min, 85°C, 5s. -20 Save for later use.
1.1.3PCR扩增1.1.3PCR amplification
(11)PCR反应体系如下(11) The PCR reaction system is as follows
PCR mixture 12.5ulPCR mixture 12.5ul
Primer 1 1ul
Primer 2 1ul
CDNA 1ulcDNA 1ul
dd H2O 9.5uldd H2O 9.5ul
(11)PCR反应条件,见表2(11) PCR reaction conditions, see Table 2
表2Table 2
*PCR反应的条件(循环数),不同的基因片段差异很大,所以试验过程中我们需要摸索出最好的条件。*The conditions (number of cycles) of the PCR reaction are very different for different gene fragments, so we need to find out the best conditions during the experiment.
1.1.4琼脂糖凝胶电泳检测扩增片段1.1.4 Detection of amplified fragments by agarose gel electrophoresis
(1)称取1g电泳级琼脂糖,加100ml 1xTBE,微波炉中加热使琼脂糖完全溶解;(1) Weigh 1g electrophoresis grade agarose, add 100ml 1xTBE, and heat in a microwave oven to completely dissolve the agarose;
(2)待胶冷却到50-60℃,加入终浓度为0.5ug/ml的EB染液摇匀;(2) After the gel is cooled to 50-60°C, add EB dye solution with a final concentration of 0.5ug/ml and shake well;
(3)用胶条封好胶板,倒入冷却到30-40℃配置好的凝胶;(3) Seal the rubber plate with glue strips, and pour the gel that has been cooled to 30-40°C;
(4)待凝胶凝固,电泳槽中加入一定量的电泳液,将胶条卸下,胶槽放到电泳槽中,使电泳液没过胶槽。轻轻拔下梳子;(4) After the gel is solidified, add a certain amount of electrophoresis liquid to the electrophoresis tank, remove the strip, and put the gel tank into the electrophoresis tank so that the electrophoresis liquid does not pass through the gel tank. Gently pull out the comb;
(5)取Marker5ul上样,将扩增好的PCR产物取8ul上样电泳,刚开始时,100V电压,待样品跑出胶孔,60V,待样品到胶2/3时,停止电泳,紫外灯下观察,拍照。(5) Take 5ul of Marker to load the sample, and take 8ul of the amplified PCR product for electrophoresis. At the beginning, the voltage is 100V, and when the sample runs out of the gel hole, 60V. Observe and take pictures under the light.
1.2免疫荧光1.2 Immunofluorescence
(1)取状态较好的IPS克隆细胞,PBS洗细胞两遍,加1ml4%多聚甲醛固定30min(1) Take IPS clone cells in good condition, wash the cells twice with PBS, add 1ml of 4% paraformaldehyde to fix for 30min
(2)弃固定液,PBS洗细胞3次,每次5min(2) Discard the fixative, wash the
(3)加1ml 0.05%通透液30min(3) Add 1ml 0.05% permeate solution for 30min
(4)弃通透液,用PBS洗细胞3次,每次5min(4) Discard the permeate, wash the cells with
(5)加500ul羊血清封闭液,1h。一抗稀释液按所需比例稀释一抗(5) Add 500ul sheep serum blocking solution, 1h. Primary Antibody Diluent Dilute the primary antibody in the desired ratio
(6)加入稀释好的一抗,置湿盒中,4℃冰箱过夜(6) Add the diluted primary antibody, put it in a wet box, and refrigerate overnight at 4°C
(7)次日取出一抗孵育的细胞,用PBS涮洗一次,在用PBS洗3次,每次10min(7) Take out the cells incubated with the primary antibody the next day, wash once with PBS, and then wash 3 times with PBS, 10min each time
(8)PBS配置二抗,弃PBS,将稀释好的二抗500ul加到细胞中(取出二抗以后的操作都应避光!)孵育1h45min.(8) Prepare the secondary antibody in PBS, discard the PBS, add 500ul of the diluted secondary antibody to the cells (after taking out the secondary antibody, the operation should be protected from light!) and incubate for 1h45min.
(9)用PBS稀释DAPI染液,按1∶2500的比例加入含有二抗的染液中,继续孵育30min(9) Dilute the DAPI staining solution with PBS, add it to the staining solution containing the secondary antibody at a ratio of 1:2500, and continue to incubate for 30 minutes
(10)弃培养皿中的液体,PBS涮洗一次,在用PBS洗3次,每次10min(10) Discard the liquid in the petri dish, rinse once with PBS, and wash 3 times with PBS, 10min each time
(11)加少量PBS,置荧光显微镜下观察(11) Add a small amount of PBS and observe under a fluorescent microscope
1.3流式细胞仪的检测1.3 Detection by flow cytometry
(1)将通过四型胶原贴壁选择的(贴壁1小时后更换培养基时)表皮干细胞,用TE消化细胞,DTI终止消化,将消化下来的细胞用预冷的含10%FBS的PBS洗细胞三遍,12000rpm,5min。(1) Digest the epidermal stem cells selected by type IV collagen attachment (when the medium is replaced after 1 hour of attachment), digest the cells with TE, stop the digestion with DTI, and use pre-cooled PBS containing 10% FBS to digest the cells Wash the cells three times, 12000rpm, 5min.
(2)用上述的PBS重悬细胞,计数稀释细胞数为5×105.(2) Resuspend the cells with the above-mentioned PBS, and count the number of diluted cells to 5×105.
(3)每份样品用100ul含3%BSA的PBS悬起细胞,加入相应抗体:10ulCD29,10ul CD90,10ul CD24,4度冰箱孵育30min。(3) Suspend the cells in 100ul PBS containing 3% BSA for each sample, add the corresponding antibodies: 10ul CD29, 10ul CD90, 10ul CD24, and incubate at 4°C for 30min.
(4)用冷的PBS洗细胞三遍,12000rpm,5min。(4) Wash the cells three times with cold PBS, 12000rpm, 5min.
(5)用3%的含BSA的PBS稀释二抗,兔抗(1∶400),鼠抗(1∶200)(5) Dilute the secondary antibody with 3% PBS containing BSA, rabbit anti-(1:400), mouse anti-(1:200)
(6)4度冰箱孵育20-30min,重复步骤四,左后用500ul冷的含BSA的PBS重悬细胞,流式细胞仪检测。(6) Incubate in a 4-degree refrigerator for 20-30 minutes, repeat step 4, resuspend the cells in 500ul of cold PBS containing BSA, and detect by flow cytometry.
2、鉴定结果:2. Identification results:
如图1所示,免疫荧光检测表皮干细胞特征标记CD90、CD24、CD29,其中CD29阳性率大于15%、CD24阳性率大于80%、CD29阳性率大于90%。如图2所示,流式细胞仪检测人包皮基底层来源的未分化角质化细胞,CD90、CD24、β1integrin为未分化角质化细胞的表面标记,其中每组图左图为对照组,右图为检测的表皮干细胞组,结果显示获得的角质化细胞干性强。如图3所示,RT-PCR鉴定培养的各时间点的表皮干细胞中干性基因,OCT4、SOX2、Klf4、Nanog、c-myc、CRIPTO、REX1、KRT14,分化标记KRT1、KRT5、KRT10、KRT19,其他细胞标记MTTF、TYR、c-kit的表达情况。As shown in Figure 1, CD90, CD24, and CD29, the characteristic markers of epidermal stem cells, were detected by immunofluorescence, wherein the positive rate of CD29 was greater than 15%, the positive rate of CD24 was greater than 80%, and the positive rate of CD29 was greater than 90%. As shown in Figure 2, undifferentiated keratinocytes derived from the basal layer of human foreskin were detected by flow cytometry. CD90, CD24, and β1integrin are the surface markers of undifferentiated keratinocytes. The left picture of each group is the control group, and the right picture For the detected epidermal stem cell group, the results show that the obtained keratinocytes have strong stemness. As shown in Figure 3, RT-PCR identified stemness genes, OCT4, SOX2, Klf4, Nanog, c-myc, CRIPTO, REX1, KRT14, and differentiation markers KRT1, KRT5, KRT10, KRT19 in epidermal stem cells at various time points in culture , the expression of other cell markers MTTF, TYR, c-kit.
目前分离干细胞的技术还达不到使分离得到的细胞纯度为100%,通过流式细胞仪检测到的结果显示我们分离得到的细胞纯度很高,其中CD29检测率达99%。同时我们用免疫荧光检测了其他细胞的分子标记,检测结果显示其他细胞存在的数量极少。The current technology for isolating stem cells is not yet able to achieve 100% purity of the isolated cells. The results detected by flow cytometry show that the cells we have isolated are of high purity, and the detection rate of CD29 is as high as 99%. At the same time, we used immunofluorescence to detect the molecular markers of other cells, and the detection results showed that there were very few other cells.
实施例2表皮干细胞定向诱导驯化为神经细胞Example 2 Directed induction and domestication of epidermal stem cells into nerve cells
1、培养基组成1. Culture medium composition
(1)神经诱导培养基一成分及用量为:(1) The components and dosage of nerve induction medium are:
DMEM/F12(Invitrogen,cat.no.11330-32);2%FBS(Gibco,cat.no.10437010)45ng/ml b-FGF(Invitrogen,cat.no.13256-029);20ng/ml EGF(invitrogen,cat.no.);0.5mM retinoic acid(RA)(sigmaR2625);0.5mM valproic acid(Sigma,cat.no.T8552);2000U/ml leukemiainhibitory factor(Chemicon,cat.lif1010);100mM sodium pyruvate(sigma,cat.no.P2256);0.5mM β-mercaptoethanol(sigma cat.no.m7522);DMEM/F12 (Invitrogen, cat.no.11330-32); 2% FBS (Gibco, cat.no.10437010) 45ng/ml b-FGF (Invitrogen, cat.no.13256-029); 20ng/ml EGF ( invitrogen, cat.no.); 0.5mM retinoic acid (RA) (sigmaR2625); 0.5mM valproic acid (Sigma, cat.no.T8552); 2000U/ml leukemia inhibitory factor (Chemicon, cat.lif1010); 100mM sodium pyruvate ( sigma, cat.no.P2256); 0.5mM β-mercaptoethanol (sigma cat.no.m7522);
(2)神经诱导培养基二成分及用量为:(2) The two components and dosage of nerve induction medium are:
DMEM/F12(Invitrogen,cat.no.11330-32)2%FBS(Gibco,cat.no.10437010);20ng/ml b-FGF(Invitrogen,cat.no.13256-029);20ng/ml EGF(invitrogen,cat.no.);0.5uM RA(sigma R2625);1×B27(invitrogen Cat.No.17504);100ug/ml butylated hydroxyanisole(sigma,cat.no.B1253)。DMEM/F12 (Invitrogen, cat.no.11330-32) 2% FBS (Gibco, cat.no.10437010); 20ng/ml b-FGF (Invitrogen, cat.no.13256-029); 20ng/ml EGF ( invitrogen, cat.no.); 0.5uM RA (sigma R2625); 1×B27 (invitrogen Cat.No.17504); 100ug/ml butylated hydroxyanisole (sigma, cat.no.B1253).
(3)干性维持培养基的成分及用量为:98%Epilife(Cascade Biologics,cat.no.M-EPI-500-CA)、1%PS双抗(双抗Invitrogen,cat.no.15070)和1%HKGS添加剂(HKGS,Cascade Biologics,cat.no.S-001-5)。(3) The composition and dosage of dry maintenance medium are: 98% Epilife (Cascade Biologics, cat.no.M-EPI-500-CA), 1% PS double antibody (double antibody Invitrogen, cat.no.15070) and 1% HKGS additive (HKGS, Cascade Biologics, cat. no. S-001-5).
2、诱导驯化方法:2. Induced domestication method:
(1)将表皮干细胞经培养后,取密度大于80%~95%的表皮干细胞,PBS洗细胞两遍,更换新鲜Eplife培养基,20~30h后在2%神经诱导培养基一和98%干性维持培养基的混合培养基中培养36h;(1) After the epidermal stem cells are cultured, take the epidermal stem cells with a density greater than 80% to 95%, wash the cells twice with PBS, replace with fresh Eplife medium, and after 20 to 30 hours, dry them in 2% neural induction medium and 98% Cultured in the mixed medium of sex maintenance medium for 36h;
(2)将培养基更换20%神经诱导培养基二和80%干性维持培养基继续培养2天;(2) The medium was replaced with 20%
(3)以后每2天更换一次培养基;每次更换神经诱导培养基二成分增加20%,直到神经诱导培养基二成分为100%而无干性维持培养基为止。(3) The medium was replaced every 2 days thereafter; the second component of the neural induction medium was increased by 20% each time, until the second component of the neural induction medium was 100% without dry maintenance medium.
实施例3目的细胞的鉴定及结果分析Identification and result analysis of the target cell of
一、免疫荧光鉴定诱导分化结果1. Immunofluorescence identification of induced differentiation results
1、鉴定方法:在诱导为神经细胞实验验证中,免疫荧光检测到神经细胞标记(a-SMA)鉴定方法如下:1. Identification method: In the experimental verification of induction of nerve cells, the identification method of the nerve cell marker (a-SMA) detected by immunofluorescence is as follows:
(1)取诱导后三周细胞以及表皮干细胞做对照,用PBS洗细胞两遍。(1) Cells three weeks after induction and epidermal stem cells were taken as controls, and cells were washed twice with PBS.
(2)每个六孔板加入4℃预冷的Tribule裂解液1ml,看到细胞均被裂解开,大约5min(2) Add 1ml of 4°C pre-cooled Tribule Lysis Solution to each six-well plate, and see that the cells are all lysed, about 5min
(3)用无核酶枪尖将细胞裂解液吸到1.5ml离心管中(3) Use a nuclease-free gun tip to suck the cell lysate into a 1.5ml centrifuge tube
(4)加入200ul氯仿,上下剧烈震荡四到五次,使其充分混匀(4) Add 200ul chloroform, shake vigorously up and down four to five times to make it fully mixed
(5)12000rpm,5min 4℃.液体分三层,吸取上层透明液体层到新的1.5ml离心管中(5) 12000rpm, 5min 4°C. The liquid is divided into three layers, and the upper transparent liquid layer is sucked into a new 1.5ml centrifuge tube
(6)加入等体积的异丙醇,上下颠倒混匀四五次,室温静止10min(6) Add an equal volume of isopropanol, mix upside down four or five times, and let stand at room temperature for 10 minutes
(7)12000rpm,5min,4℃此时可见RNA沉淀,弃上清,注意小心操作勿将沉淀块吸出(7) 12000rpm, 5min, 4°C, RNA precipitation can be seen at this time, discard the supernatant, and be careful not to suck out the precipitate
(8)加预冷的70%乙醇700ul,12000,2min,4℃,弃上清,重复操作一次(8) Add 700ul of pre-cooled 70% ethanol, 12000, 2min, 4°C, discard the supernatant, repeat the operation once
(9)将RNA中残留的液体晾干,视沉淀体积量加入无核酶水溶解RNA(注意RNA太干不易溶解)(9) Dry the remaining liquid in the RNA, and add nuclease-free water to dissolve the RNA depending on the volume of the precipitate (note that the RNA is too dry and difficult to dissolve)
2、鉴定结果:2. Identification results:
分别在驯化诱导后10天、2周、3周免疫荧光检测到表皮细胞特异性标记(involucrin阳性)、神经细胞特异性标记(nestin)。如图5所示,为驯化诱导角质化细胞产生神经细胞系,A代表诱导前的角质化细胞和诱导两天后的细胞;B箭头指示为诱导两周后角质化来源的Nestin阳性的细胞;C箭头指示诱导三周后神经特异标记β3-tublin免疫荧光结果;D箭头指示为GFAP阳性的细胞,右图为角质化细胞诱导来的6FAP阳性的典型的胶质细胞分化形态;E的为神经诱导三周后RT-PCR分析基因的表达,M,marker;K,分化的角质化细胞;S,sample;Epidermal cell-specific markers (involucrin positive) and nerve cell-specific markers (nestin) were detected by immunofluorescence at 10 days, 2 weeks, and 3 weeks after acclimation induction, respectively. As shown in Figure 5, neural cell lines were generated for domestication and induction of keratinocytes, A represents keratinocytes before induction and cells two days after induction; B arrows indicate Nestin-positive cells derived from keratinization two weeks after induction; C Arrows indicate the immunofluorescence results of the nerve-specific marker β3-tublin after three weeks of induction; D arrows indicate GFAP-positive cells, and the right picture shows the typical glial cell differentiation morphology of 6FAP-positive cells induced by keratinocytes; E shows nerve induction Three weeks later, RT-PCR analysis of gene expression, M, marker; K, differentiated keratinocytes; S, sample;
图4为表皮细胞起始状态及诱导两天后的状态。左图为起始诱导的表皮干细胞生长状态;右图为驯化诱导培养两天后的表皮干细胞的生长状态(可以作为参考指标)Figure 4 shows the initial state of epidermal cells and the state after two days of induction. The left picture shows the growth state of epidermal stem cells induced initially; the right picture shows the growth state of epidermal stem cells after two days of acclimation induction (can be used as a reference index)
图6为定向诱导驯化后神经(nestin)特异性染色阳性。Figure 6 shows the positive staining of neural (nestin) specificity after directional induction and domestication.
二、RT-PCR鉴定诱导分化结果2. RT-PCR Identification of Induced Differentiation Results
1、RNA提取1. RNA extraction
(1)取诱导后三周细胞以及表皮干细胞做对照,用PBS洗细胞两遍。(1) Cells three weeks after induction and epidermal stem cells were taken as controls, and cells were washed twice with PBS.
(2)每个六孔板加入4℃预冷的Tribule裂解液1ml,看到细胞均被裂解开,大约5min(2) Add 1ml of 4°C pre-cooled Tribule Lysis Solution to each six-well plate, and see that the cells are all lysed, about 5min
(3)用无核酶枪尖将细胞裂解液吸到1.5ml离心管中(3) Use a nuclease-free gun tip to suck the cell lysate into a 1.5ml centrifuge tube
(4)加入200ul氯仿,上下剧烈震荡四到五次,使其充分混匀(4) Add 200ul chloroform, shake vigorously up and down four to five times to make it fully mixed
(5)12000rpm,5min 4℃.液体分三层,吸取上层透明液体层到新的1.5ml离心管中(5) 12000rpm, 5min 4°C. The liquid is divided into three layers, and the upper transparent liquid layer is sucked into a new 1.5ml centrifuge tube
(6)加入等体积的异丙醇,上下颠倒混匀四五次,室温静止10min(6) Add an equal volume of isopropanol, mix upside down four or five times, and let stand at room temperature for 10 minutes
(7)12000rpm,5min,4℃此时可见RNA沉淀,弃上清,注意小心操作勿将沉淀块吸出(7) 12000rpm, 5min, 4°C, RNA precipitation can be seen at this time, discard the supernatant, and be careful not to suck out the precipitate
(8)加预冷的70%乙醇700ul,12000,2min,4℃,弃上清,重复操作一次(8) Add 700ul of pre-cooled 70% ethanol, 12000, 2min, 4°C, discard the supernatant, repeat the operation once
(9)将RNA中残留的液体晾干,视沉淀体积量加入无核酶水溶解RNA(注意RNA太干不易溶解)(9) Dry the remaining liquid in the RNA, and add nuclease-free water to dissolve the RNA depending on the volume of the precipitate (note that the RNA is too dry and difficult to dissolve)
2、逆转录RNA为CDNA2. Reverse transcription of RNA to cDNA
(10)按反转录试剂盒配置反转录体系,见表3:(10) Configure the reverse transcription system according to the reverse transcription kit, see Table 3:
表3table 3
*RNA加入的多少应视沉淀量而定,最后无核酶水的量应补足到10ul*The amount of RNA added should depend on the amount of precipitation, and the amount of nuclease-free water should be supplemented to 10ul
按上表加入好后,37℃,15min,85℃,5s。-20保存待用。After adding according to the above table, 37°C, 15min, 85°C, 5s. -20 Save for later use.
3.PCR扩增3.PCR amplification
(1)PCR反应体系如下(1) The PCR reaction system is as follows
PCR mixture 12.5ulPCR mixture 12.5ul
Primer 1 1ul
Primer 2 1ul
CDNA 1ulcDNA 1ul
dd H2O 9.5uldd H2O 9.5ul
(2)PCR反应条件见表4(2) PCR reaction conditions are shown in Table 4
*PCR反应的条件(循环数),不同的基因片段差异很大,所以试验过程中我们需要摸索出最好的条件*The conditions (number of cycles) of the PCR reaction are very different for different gene fragments, so we need to find out the best conditions during the experiment
表4:Table 4:
4、琼脂糖凝胶电泳检测扩增片段4. Detection of amplified fragments by agarose gel electrophoresis
(1)称取1g电泳级琼脂糖,加100ml 1xTBE,微波炉中加热使琼脂糖完全溶解(1) Weigh 1g electrophoresis grade agarose, add 100ml 1xTBE, heat in a microwave oven to completely dissolve the agarose
(2)待胶冷却到50-60℃,加入终浓度为0.5ug/ml的EB染液摇匀(2) After the gel is cooled to 50-60°C, add EB dye solution with a final concentration of 0.5ug/ml and shake well
(3)用胶条封好胶板,倒入冷却到30-40℃配置好的凝胶(3) Seal the rubber plate with glue strips, and pour the gel that has been cooled to 30-40°C and prepared
(4)待凝胶凝固,电泳槽中加入一定量的电泳液,将胶条卸下,胶槽放到电泳槽中,使电泳液没过胶槽。轻轻拔下梳子(4) After the gel is solidified, add a certain amount of electrophoresis liquid to the electrophoresis tank, remove the strip, and put the gel tank into the electrophoresis tank so that the electrophoresis liquid does not pass through the gel tank. Gently pull out the comb
(5)取Marker5ul上样,将扩增好的PCR产物取8ul上样电泳,刚开始时,100V电压,待样品跑出胶孔,60V,待样品到胶2/3时,停止电泳,紫外灯下观察,拍照。结果见图5E的为神经诱导三周后RT-PCR分析基因的表达,M,marker;K,分化的角质化细胞;S,sample。(5) Take 5ul of Marker to load the sample, and take 8ul of the amplified PCR product for electrophoresis. At the beginning, the voltage is 100V, and when the sample runs out of the gel hole, 60V. Observe and take pictures under the light. The results shown in Figure 5E are RT-PCR analysis of gene expression three weeks after neural induction, M, marker; K, differentiated keratinocytes; S, sample.
三、诱导结果:3. Induction results:
我们制备表皮干细胞的标本数133例,定向诱导15例,100%成功。经过上述定向诱导我们证明了表皮干细胞能成功定向分化神经细胞。We prepared 133 specimens of epidermal stem cells, 15 cases of directional induction, 100% success. After the above directed induction, we proved that epidermal stem cells can successfully differentiate into neural cells.
四、本发明用途:Four, purposes of the present invention:
表皮干细胞在非定向培养系统中,能定向分化成为神经细胞,证实了表皮干细胞非单能干细胞,它具有明确的多向分化潜能。表皮干细胞在人体分布广泛,取材容易,干细胞活性不受年龄限制又具有良好的体外扩增能力,这些都将为其在成体干细胞应用领域中增添优势。Epidermal stem cells can differentiate into nerve cells in a non-directed culture system, which proves that epidermal stem cells are not unipotent stem cells, and they have a clear potential for multidirectional differentiation. Epidermal stem cells are widely distributed in the human body, easy to obtain materials, stem cell activity is not limited by age, and have good in vitro expansion ability, which will add advantages to the application field of adult stem cells.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910210397 CN101760447B (en) | 2009-10-30 | 2009-10-30 | Method for inducing and acclimating epidermal stem cells into nerve cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910210397 CN101760447B (en) | 2009-10-30 | 2009-10-30 | Method for inducing and acclimating epidermal stem cells into nerve cells |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101760447A CN101760447A (en) | 2010-06-30 |
CN101760447B true CN101760447B (en) | 2013-04-03 |
Family
ID=42491826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200910210397 Expired - Fee Related CN101760447B (en) | 2009-10-30 | 2009-10-30 | Method for inducing and acclimating epidermal stem cells into nerve cells |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101760447B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106978389A (en) * | 2017-05-05 | 2017-07-25 | 广州市天河诺亚生物工程有限公司 | A kind of combination culture medium for cultivating amniotic epithelial cells |
CN110408594A (en) * | 2019-07-31 | 2019-11-05 | 吉林大学 | A method for efficient and massive reprogramming of human fibroblasts into mature neurons |
CN110628696B (en) * | 2019-08-28 | 2021-09-07 | 郑州大学 | Small molecule composition for directionally inducing cell differentiation and preparation method of retinal pigment epithelial cells |
CN111733133B (en) * | 2020-07-22 | 2020-12-01 | 华夏源(上海)生命科技有限公司 | A method for promoting differentiation and growth of epidermal stem cells |
CN113462636B (en) * | 2021-08-05 | 2023-11-14 | 合肥滴碧云生物科技有限公司 | Improved method for differentiating epidermal stem cells into liver cells |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5786323A (en) * | 1994-11-16 | 1998-07-28 | Amgen Inc. | Use of stem cell factor and soluble interleukin-6 receptor to induce the development of hematopoietic stem cells |
CN1810960A (en) * | 2006-01-13 | 2006-08-02 | 深圳市北科生物科技有限公司 | Method of inducing differentiation of human amnion mesenchyme stem cell to nerve cell |
-
2009
- 2009-10-30 CN CN 200910210397 patent/CN101760447B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5786323A (en) * | 1994-11-16 | 1998-07-28 | Amgen Inc. | Use of stem cell factor and soluble interleukin-6 receptor to induce the development of hematopoietic stem cells |
CN1810960A (en) * | 2006-01-13 | 2006-08-02 | 深圳市北科生物科技有限公司 | Method of inducing differentiation of human amnion mesenchyme stem cell to nerve cell |
Non-Patent Citations (2)
Title |
---|
Phinney DG, ET AL.PLASTICITY AND THERAPEUTIC POTENTIAL OF MESENCHYMAL STEM CELLS IN THE NERVOUS SYSTEM.《CURR PHARM DES》.2005,第11卷(第10期),1255-1265. * |
雷永红,等.成体干细胞生物学的研究进展.《感染、炎症、修复》.2005,第6卷(第3期),165-169. * |
Also Published As
Publication number | Publication date |
---|---|
CN101760447A (en) | 2010-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cheng et al. | The influence of spheroid formation of human adipose-derived stem cells on chitosan films on stemness and differentiation capabilities | |
Han et al. | Differentiation of human umbilical cord mesenchymal stem cells into dermal fibroblasts in vitro | |
CN103146572B (en) | A kind of apparatus and method realizing the growth of cell colony uniformity | |
US20250109385A1 (en) | Compositions and methods for using small mobile stem cells | |
CN101760447B (en) | Method for inducing and acclimating epidermal stem cells into nerve cells | |
Kermani et al. | Characterization and genetic manipulation of human umbilical cord vein mesenchymal stem cells: potential application in cell-based gene therapy | |
CN107217028B (en) | Tissue engineering skin containing accessory and preparation method thereof | |
Liu et al. | Muse cells, a new type of pluripotent stem cell derived from human fibroblasts | |
Benda et al. | Urine as a source of stem cells | |
CN102344906A (en) | Hair follicle stem cell separation culture method | |
Cho et al. | Generation of human secondary cardiospheres as a potent cell processing strategy for cell-based cardiac repair | |
Kumar et al. | Hair & skin derived progenitor cells: In search of a candidate cell for regenerative medicine | |
CN101760449B (en) | Method for inducing and domesticating epidermal stem cells into muscle cells | |
CN101875915A (en) | Method for inducing and domesticating epidermal stem cells into adipocytes | |
Wang et al. | Hair follicle stem cells isolated from newborn Yangtze River Delta White Goats | |
Bhuvanalakshmi et al. | Multifunctional properties of chicken embryonic prenatal mesenchymal stem cells-pluripotency, plasticity, and tumor suppression | |
Wu et al. | hMSCs possess the potential to differentiate into DP cells in vivo and in vitro | |
Adib et al. | Molecular assessment, characterization, and differentiation of theca stem cells imply the presence of mesenchymal and pluripotent stem cells in sheep ovarian theca layer | |
Moghaddam Matin et al. | Blastema cells derived from rabbit ear show stem cell characteristics | |
CN107267444B (en) | Culture medium and application thereof, and method for transforming mesenchymal stem cells into sweat gland-like cells | |
Yang et al. | Isolation and culture of neural crest stem cells from human hair follicles | |
Nansubuga et al. | Efficient generation of human pluripotent stem cells from frozen cord tissue via chemical reprogramming | |
CN110093306A (en) | Artificial hair follicle and its preparation method and application | |
CN101760448B (en) | Method for inducing and domesticating epidermal stem cells into functional cells | |
CN111662864A (en) | Method for differentiating umbilical cord mesenchymal stem cells into dermal stem cells through in-vitro induction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130403 Termination date: 20161030 |